I'm speaking and chairing a panel at the 30th annual "TRI CON" conference for Molecular & Precision Medicine, in San Diego March 6-8, 2023.
There are multiple tracks, some of which partially share events. I'm in the Tuesday-Wednesday track, "Diagnostics Innovation and Market Access," and on Wednesday afternoon our topic is "Reimbursement Strategies for Advanced Diagnostics." Nicholas Halzack of Roche will discuss PAMA Reform and parallel efforts; I'll discuss Medicare's plans for better coverage of transitional technology; and Dr Bien-Willner of MolDx will "Demystify Molecular Diagnostics Coverage & Reimbursement in Medicare - MolDx."
A partial list of speakers in this track on Tuesday-Wednesday will include Lon Castle of eviCore, Mathew Fickie of Highmark, John Fox and Damon Hostin of Illumina, Mara Aspinall of ASU and Bluestone Ventures, Ajit Singh of RA Artiman Ventures, John Szajka of BD, Bruce Tromberg of NIH/RADx, Lauren Feldman of ADVI, Suzaane Belinson of Tempus, Shaunna Kobilis of Adaptive Biotechnologies..
More info here including a discount code:
CHI’s 30th International Molecular & Precision Med Tri-Con, March 6-8, 2023 in San Diego. Visit www.triconference.com for detailed program and to register, plus you can use my code “LI200” for additional $200 discount.
